Acadia Pharmaceuticals | ACAD - Ebitda





Ebitda Veränderung Datum
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
ALKERMES USD 139.22M 58.96M 2026-06
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Biogen USD 649.7M 76.5M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Cara Therapeutics USD -2.39M 3.16M 2025-03
Corcept Therapeutics USD -49M 53.2M 2026-03
Cytokinetics USD -169.32M 19.48M 2026-03
Eisai JPY 34.15B 34.48B 2026-06
Eli Lilly USD 10.29B 1.86B 2026-03
Incyte USD 778.57M 410.6M 2026-06
J&J USD 8.99B 721M 2026-06
Moderna USD -1.26B 468M 2026-03
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Pfizer USD 6.01B 18M 2026-06
Prothena USD 25.98M 65.51M 2026-03
PTC Therapeutics USD 161.9M 99.92M 2026-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06